These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement ...

Earlier, the company said it brought back dire wolves, which had been extinct for more than 12,000 years. It also has created ...

Biotech companies create drugs from living organisms, requiring a BLA for FDA approval. Pharma companies develop drugs from chemicals, needing an NDA for FDA approval. Many firms blend biotech and ...

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

In this interview Prof. Dr. Kristina Kusche-Vihrog speaks about the nanomechanics of living cells and their implications for cardiovascular disease. Molecular Devices' CellXpress AI streamlines ...

Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s ...

The downsizing is planned for May 12. — Cargo Therapeutics, 84 layoffs in San Carlos. The biotech company is halting development and is closing its San Carlos site. The downsizing is planned for ...

Verley, a French biotech company specializing in sustainable food solutions, launched a portfolio of functionalized precision fermentation dairy proteins, designed to overcome the limitations of both ...

Alcon's acquisition of Aurion Biotech enhances its cell therapy capabilities for eye diseases, with Aurion operating independently under Alcon's support. Aurion's AURN001, an allogeneic cell therapy ...